Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ralph Boccia (NPI 1881663284)

Field	Value
Entity Type	Individual
Organization	Ralph Boccia
Address	6410 Rockledge Dr
City	Bethesda
State	MD
ZIP	20817
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	March 16, 2006

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider’s billing footprint is effectively single‑payer: total Medicare revenue is $2.5M and there is no Medicaid billing on file (none). The NPI was enumerated on 2006-03-16 (~20 years ago), indicating a long-tenured practice presence in Bethesda, MD that is primarily Medicare-facing.

Revenue is heavily concentrated in a small set of drug administration codes: the precomputed top three Medicare codes account for 68.5% of this provider’s total Medicare revenue. The three drivers are J9144 ($868.3K, 34.7%), J1569 ($677.1K, 27.1%), and J0885 ($167.1K, 6.7%), so most Medicare dollars flow through high-cost injectable therapies.

The code mix and volumes point to an infusion- and procedure-focused hematology/oncology practice: J9144 (24.1K claims, $36 avg paid/claim, $868.3K revenue) and J1569 (18.8K claims, $36 avg paid/claim, $677.1K revenue) dominate revenue, consistent with routine administration of biologic therapies and immune globulin. High claim counts for infusion-related services (e.g., 96365 with 611 claims) and chemotherapy administration codes (96413, 96401) further indicate an on-site infusion workflow.

On competitive standing, the provider is a major national participant for several top drugs: J1569 ranks #11 of 542 providers nationally (98th percentile; notably above typical national volume) and J9144 ranks #32 of 615 providers nationally (94th percentile; notably above typical national volume). These ranks suggest above-average national scale for administration of these specific agents relative to peers.

There are pronounced statistical outliers in the portfolio: J0885 (27.9K claims, $6 avg paid/claim, $167.1K revenue) ranks #3 of 953 providers nationally (100th percentile; extreme outlier), and selected E/M and infusion administration codes such as 99214 (1.5K claims, $106 avg paid/claim, $162.3K revenue) and 96372 (1.5K claims, $12 avg paid/claim, $18.1K revenue) are labeled as extreme outlier or extreme outlier-level volume. These designations indicate utilization far above typical national volumes for those services and may reflect a very high throughput infusion operation or specialty clinic workflows.

The practice maintains substantial office evaluation and management volume alongside infusion services: 99214 (1.5K claims, $162.3K revenue, 6.5% of Medicare revenue) and 99213 (1.3K claims, $93.8K revenue, 3.7% of Medicare revenue) together represent meaningful non-drug revenue and suggest ongoing longitudinal management of established patients in addition to infusion visits. High percentiles for these E/M codes (both in the 99th percentile) underscore unusually large outpatient panel activity relative to national peers.

Ancillary testing is present and consistent with hematology/oncology care pathways: routine lab codes such as 85025 (3.2K claims, $26K revenue), 80053 (1.2K claims, $12.1K revenue), 82728 (553 claims, $7.2K revenue) and specialized markers like 82232 (230 claims, $3.7K revenue) indicate on-site or closely integrated lab monitoring for therapy management and iron/metabolic surveillance. The mix of lab and bone marrow procedure code 38222 (31 claims, $4.9K revenue) supports diagnostic and monitoring services typical for this specialty.

From a payer-negotiation and business-risk perspective, the practice’s heavy reliance on a small set of high-volume injectable products—J9144, J1569, and J0885 making up 68.5% of Medicare revenue—creates concentration risk: changes in utilization, reimbursement, or drug acquisition costs for these agents would disproportionately affect overall Medicare revenue. Given the lack of Medicaid billing (none), the provider’s financial exposure and strategic leverage are tightly coupled to Medicare drug and infusion policies and to maintaining high infusion throughput.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

43 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	24,120	$40	$868.3K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	18,810	$40	$677.1K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	27,850	$10	$167.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,530	$110	$162.3K
J1437	Injection, ferric derisomaltose, 10 mg	8,400	$20	$134.4K
J0897	Injection, denosumab, 1 mg	6,780	$20	$122K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,250	$80	$93.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	330	$120	$40.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	610	$60	$34.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	200	$150	$29.7K

Showing 1–10 of 43

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Ralph Boccia — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

43 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9144	3	30	11,970	$40	$493.5K
J1569	1	10	3,440	$40	$203K
J0897	101	340	3,600	$20	$114.4K
J0881	57	60	30,420	$1	$76.4K
J1437	8	50	2,800	$20	$75.1K
J0885	2	20	4,800	$10	$43.2K
96413	66	230	200	$110	$29.6K
99214	156	10,270	150	$90	$24.1K
Q0138	5	40	28,050	$1	$17.5K
80053	37	430	250	$10	$13.1K

Showing 1–10 of 43

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ralph Boccia, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wilfredo Blasini	FL	Clinical Pathology Physician	$16.9M	$307.9K
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
American Oncology Partners PA	OH	Hematology & Oncology Physician	$0	$11.8M
Robert Mcdonald	AZ	Diagnostic Radiology Physician	$7.5M	$0
David Smith	MD	Hematology & Oncology Physician	$6.4M	$0
Stephen Divers	AR	Hematology & Oncology Physician	$3.9M	$1.5K
Robert Muldoon	AR	Hematology & Oncology Physician	$3.2M	$0
Bradley Sumrall	GA	Medical Oncology Physician	$3.1M	$0
Linda Hendricks	GA	Specialist	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Ralph Boccia, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Khiet Nguyen	MD	Diagnostic Radiology Physician	$1.6M	$0
Jason Marquart	MD	MOHS-Micrographic Surgery Physician	$1.5M	$0
Stephen Greco	MD	Radiation Oncology Physician	$1.3M	$0
Johns Hopkins Surgery Centers Series	MD	Ambulatory Surgical Clinic/Center	$1.2M	$0
Surgical Specialty Center Of Mid Atlantic, LLC	MD	Ambulatory Surgical Clinic/Center	$1.1M	$0
Carolyn Hendricks	MD	Specialist	$1.1M	$0
Srinivas Sastry	MD	Ophthalmology Physician	$1M	$0
Christopher Cannova	MD	Specialist	$961.4K	$0
Capitol Surgical Center LLC	MD	Ambulatory Surgical Clinic/Center	$932.8K	$0
Chitra Rajagopal	MD	Hematology & Oncology Physician	$893.1K	$0

Ralph Boccia — Billing Profile & Reimbursement Data

Sign up for Ralph Boccia — Billing Profile & Reimbursement Data policy alerts

Ralph Boccia — Billing Profile & Reimbursement Data

Sign up for Ralph Boccia — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References